At EuroEcho 2021, the scientific congress of the European Society of Cardiology (ESC), you can catch the latest developments in cardiovascular imaging – including gender differences as well as long COVID. You can also be prepared for the most significant advancements in cardiovascular imaging.
Stay tuned for a session on post-COVID challenges , featuring new discoveries from centers that treat patients with the virus. Dr. Denisa Muraru, scientific program chair she said: “After several waves of the pandemic, a major issue is for those who have recovered from COVID-19, but still have symptoms. Imaging plays a crucial function in identifying the root of symptoms, as well as determining whether there are any serious cardiovascular conditions that could have developed after the infection. The conference will also present results of an ESC survey on cardiac imager burnout in the pandemic. The event will include experts in imaging who will discuss their experiences in the delivery of services in their countries as well as the difficulties they faced to ensure that patients received the best care.
Professor Leyla Elif Sade, scientific program chair, said: “COVID-19 hits the young as well, and here an understanding of the cardiac involvement through imaging is essential. COVID-19 presents with different symptoms and treatment options. Imaging is a method to evaluate the effectiveness of treatment.
Explore the scientific programme of the leading echocardiography congress. The event will take place from 9-11 December at hub27 in Berlin, Germany, and online.
Novel research will be presented in hundreds of abstracts , among them:
- Machine learning is used to predict mortality in patients suffering from suspected or confirmed heart disease.
- Bariatric surgery can have an impact on the functioning of the heart.
- Cardiac effects of COVID-19 infection
- Innovative imaging techniques to evaluate the cardiotoxicity of cancer treatments.
- Air pollution and its impact on the results of heart function tests
- Deep learning to interpret echocardiographic measurements.
Sessions to be missed: Imaging the female heart for a deeper look at gender differences in valve disease Ischemic heart disease and other issues. “Declining death rates from coronary artery disease have been less evident in women when as compared to males,” said Dr. Muraru. Dr. Muraru stated that women are less successful in the aftermath of having a heart attack than males and are less likely to receive the best guideline-directed medical treatment. Additionally, certain diseases are more prevalent among females than males for instance, myocardial infarction that is non-obstructive coronary arteries. It isn’t clear if these discrepancies are due in part to gender-related biological differences, or the misdiagnosis or undertreatment of females. This meeting will provide current insights and help us better understand the issue.
Valvular and ischemic heart diseases are among the top causes of heart failure and are themes at this year’s congress.State-of-the-art imaging approaches will be presented to help healthcare professionals implement recommendations from the 2021 valvular heart disease guidelines into their clinical practice. Other hot topics include the treatment of asymptomatic patients with severe Aortic Stenosis and the use of imaging to identify and eliminate complications during transcatheter heart valve procedures.
The elderly are more prone to valvular diseases but less able to undergo surgery, and percutaneous procedures require imaging guidance. Imaging is now able to treat previously untreatable conditions such as severe functional regurgitation of the tricuspid. We will be hearing about the most recent developments in imaging and the latest treatments at the conference.
Professor Leyla Elif Sade
While echocardiography is the primarystay of cardiovascular imaging, many other techniques are utilized to make clinical decisions – which is the reason “echocardiography and multimodality imaging” is another congress theme. These include cardiac magnetic resonance, computed Tomography, and nuclear cardiology. Dr. Muraru said that attendees will be taught how to incorporate cutting-edge technological advancements into their clinical practice to improve the quality of care for patients. “Topics that are of particular interest include multimodality cardiac imaging in patients with cancer or congenital heart disease or COVID-19.”
EuroEcho is an annual gathering of experts and scientists from all over the world. Sign up today to receive news releases about the top event in this field.
Content Source: https://www.news-medical.net/news/20211116/EuroEcho-2021-to-highlight-latest-developments-in-cardiovascular-imaging.aspx